Our innovative plan
We’re set to be a part of the way the world delivers its healthcare with an innovative, science-based approach to developing and delivering cannabinoid products to those who need them the most. Our robust research, innovative product development, partnerships with global industry-leading companies and agreements for future sales put us in a unique position to create value and carve out a significant share of this emerging and exciting industry in New Zealand and globally.
Committed to scientific, health-based success
Our team of professionals in medicine, biochemistry, governance, and sales are committed to providing assurance from seed-to-sale. Medical Kiwi’s operations will cover the full process from cultivation to the production of rapidly evolving consumer goods. Our seed-to-sale vertical integration approach will set us apart from other companies in New Zealand who might focus solely on cultivation or research.
First-to-market with naturally effective products
Scientists believe the chemical molecules in cannabis can provide a range of physical and psychological health benefits. As scientists learn more about the therapeutic benefits and pharmaceutical uses, demand is increasing. Medical Kiwi is well positioned to take advantage of rising demand and legislative changes to create first-mover advantage.
Innovators and leaders in the industry
Scientists believe the chemical molecules in cannabis can provide a range of physical and psychological health benefits. And as scientists learn more about the therapeutic benefits and pharmaceutical uses, demand is increasing. Medical Kiwi is committed to an advanced research and technology programme to set standardisation of the beneficial properties of extracts.